BI 1432-0001

Status: | Marker: KRAS Title A phase I open-label dose escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumours Study Number Indication Solid Tumor with previously-identified...

CLXH254X2102

Status: | Marker: BRAF, KRAS Title Study Number Indication Primary Objective In- and exclusion Criteria Study Design Responsibilities Trial Centre Principal investigator Letzte...